CHAPTERS
Reconnecting after years: Strassman’s early research legacy and why it mattered
Joe and Rick reconnect and recall first meeting in the mid-2000s, before the podcast era. Joe frames Strassman’s DMT work as a landmark: one of the first major U.S. human psychedelic studies after a long research drought.
First altered states: hash, shared hallucinations, and a chemistry mind getting hooked
Strassman describes a powerful first marijuana/hash experience in 1970, including vivid, seemingly shared hallucinations. The story becomes a springboard into how chemical changes can radically alter perception—and why he wanted to study them scientifically.
Psychedelics and mental stability: vulnerability, psychosis, and ‘thin veneer of normality’
Joe and Rick pivot to risks: how heavy psychedelic use can destabilize vulnerable people and resemble psychosis. They explore genetic predisposition, life stressors, and why expanded access could recreate some of the harms seen in the 1960s.
When the trip doesn’t end: McKenna’s story and the ‘portal that stayed open’ model
The conversation turns to prolonged altered states, including the McKenna/Lancho Huerta mushroom story as Joe remembers it. Strassman offers a metaphorical model: psychedelics can ‘open a portal’ that may not close quickly for some individuals.
Is the DMT realm an objective ‘place’? Experiments, VR transcendence, and near-death parallels
Joe presses on whether DMT experiences could be access to an external dimension and how one might test that. They discuss VR research claiming transcendence-like experiences and connect near-death experiences to endogenous DMT findings.
Endogenous DMT in the brain: pineal controversies, death spikes, and a possible neurotransmitter system
Strassman summarizes newer research showing endogenous DMT in mammalian brains and increases around death—especially in visual regions. They unpack the contentious pineal gland hypothesis and a bigger possibility: DMT functioning like a neurotransmitter system regulating ordinary reality.
Pineal mystique and dark detours: ancient reverence, Aztec stories, prion disease, and eating brains
From pineal symbolism, the discussion veers into why cultures mythologized brain organs—then into unsettling accounts of ritual practices and the biological risks of eating brain tissue. Joe and Rick connect this to prion diseases like CJD and “mad cow.”
Modern life, tech avoidance, and social anxiety: flip phones, small towns, Monkeypox, and hope
A lighter interlude about Strassman’s flip phone turns into a critique of screen-driven outrage and information overload. They briefly touch Monkeypox, then shift into what sustains optimism amid corruption, fear, and historical atrocities.
How Strassman got DMT studies approved: decades of training, melatonin research, and careful strategy
Strassman lays out the long path: early ambition to merge Freud, Buddhism, and psychopharmacology; rejection from medical schools; then rigorous clinical research training through melatonin/pineal work. He explains how institutional support and cautious framing made the DMT study possible.
Funding from unexpected places: NIDA, the War on Drugs framing, and the Scottish Rite/Masons grant
Strassman reveals the pragmatic framing used to secure funding: position DMT as potentially linked to psychosis and public health, not spirituality. He also recounts early support from the Scottish Rite Foundation for Schizophrenia Research—fueling discussion of symbolism and conspiracy interpretations.
Religion and legality: UDV & Santo Daime exemptions, Oregon’s psilocybin model, and policy tradeoffs
They explore how Brazilian ayahuasca churches gained U.S. religious protections after importation was discovered and litigated. The conversation broadens to Oregon’s psilocybin centers, banking/cash problems from cannabis legalization, and how education might reduce harm in wider legalization.
5-MeO-DMT, lingering ‘slippery reality,’ and the need for integration support
Joe and Rick compare difficult after-effects: Joe’s two-week post-DMT instability and Strassman’s unsettling 5-MeO-DMT experience. They discuss addictive patterns with 5-MeO, overuse warnings, therapy as integration, and how bad experiences can resemble PTSD-like trauma.
Designing a human DMT protocol: IV vs smoking, dosing, early overdoses, and shared-experience questions
Strassman explains why the study used IV DMT (precision, speed, no combustion byproducts) and how dose-response research works. He recounts early overestimates leading to overwhelming sessions, then discusses uniformity of reports and Joe’s interest in simultaneous dosing for telepathy-style studies.
Human evolution, stoned ape, and the ‘field’ idea: DMT as a shared language across life
They connect psychedelics to big-picture theories: Julian Jaynes’ bicameral mind, McKenna’s stoned ape hypothesis, and how neuroplasticity/neurogenesis could influence development. Strassman adds speculative models of DMT as a kind of ‘spiritual Esperanto’ enabling communication within a broader field.
The future of psychedelics: centers vs government control, MKUltra cautions, and a new handbook release
They debate legalization models—recreational vs medical, state-by-state vs federal, and the risks of government overreach. The conversation includes MKUltra/Manson as a caution about suggestibility, then returns to harm reduction and Strassman’s newly released ‘The Psychedelic Handbook’ focused on how to trip safely.
